Literature DB >> 24697226

The vasodilatory activity of CGRP: a response.

Marcelo E Bigal1, Sarah Walter, Alan M Rapoport.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24697226     DOI： 10.1111/head.12316

Source DB:  PubMed          Journal:  Headache        ISSN： 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  2 in total

Review 1.  TEV-48125: a review of a monoclonal CGRP antibody in development for the preventive treatment of migraine.

Authors:  Sarah Walter; Marcelo E Bigal
Journal:  Curr Pain Headache Rep       Date:  2015-03

Review 2.  Targeting CGRP: A New Era for Migraine Treatment.

Authors:  Stephanie Wrobel Goldberg; Stephen David Silberstein
Journal:  CNS Drugs       Date:  2015-06       Impact factor: 5.749
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.